2021
DOI: 10.1080/08164622.2021.1896943
|View full text |Cite
|
Sign up to set email alerts
|

Vitreomacular traction spontaneous resolution after pharmacological mydriasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Due to his disease's uncontrolled progression and the patient's reluctance towards surgical treatment, the patient was started on pilocarpine 1% ophthalmic solution OU. Due to the adverse effects reported with pilocarpine use in recent literature, 4 , 5 , 6 our patient had a baseline fundoscopic examination and a macular SD-OCT prior to the initiation of treatment. At the time, macular SD-OCT showed the absence of a complete posterior vitreous detachment and vitreomacular adhesion without traction ( Fig.…”
Section: Case Reportmentioning
confidence: 99%
See 1 more Smart Citation
“…Due to his disease's uncontrolled progression and the patient's reluctance towards surgical treatment, the patient was started on pilocarpine 1% ophthalmic solution OU. Due to the adverse effects reported with pilocarpine use in recent literature, 4 , 5 , 6 our patient had a baseline fundoscopic examination and a macular SD-OCT prior to the initiation of treatment. At the time, macular SD-OCT showed the absence of a complete posterior vitreous detachment and vitreomacular adhesion without traction ( Fig.…”
Section: Case Reportmentioning
confidence: 99%
“…In 2021, Torregrossa et al reported a case of vitreomacular traction syndrome that spontaneously resolved with topical tropicamide 1%. 4 In 2007, Walker et al reported a case of VTS following administration of topical pilocarpine 2% for the reversal of pharmacological mydriasis. 6 In 2022, Al-Khersan et al published a series of rhegmatogenous retinal detachments associated with the use of pilocarpine for presbyopia (Pilocarpine 1.25%).…”
Section: Introductionmentioning
confidence: 99%